首页> 外文期刊>Medicine. >Urinary tract infection control in intensive care patients
【24h】

Urinary tract infection control in intensive care patients

机译:重症监护患者的尿路感染控制

获取原文
获取外文期刊封面目录资料

摘要

This retrospective study tried to find the potential approach for reducing the urinary tract infection (UTI) in intensive care patients (ICPs) among adult population. In total, 96 eligible ICP cases were included. Of these, 48 cases received 10% povidone-iodine and were assigned to the intervention group, while the other 48 cases underwent sterile water, and were assigned to the control group for the prevention of catheter-associated UTI before indwelling urinary catheter insertion in ICP. The primary outcome was the occurrence of an UTI after the indwelling catheter. The secondary outcome was the identification of pathogenic species. The outcomes were assessed after catheter removed. After catheter removal, the occurrence of an UTI did not differ significantly between the 2 groups ( P = .34). In addition, no significant differences regarding the pathogenic species were detected between the 2 groups ( Escherichia coli , P = .73; Candida albicans , P = .57; Enterococcus, P = .65; Proteus mirabilis , P = .50; Citrobacter, P = .50; Klebsiella pneumoniae , P = .57). The use of 10% povidone-iodine may not help reducing UTI in ICP.
机译:这项回顾性研究试图寻找减少成人人群中重症监护患者(ICPs)尿路感染(UTI)的潜在方法。总共包括96例符合条件的ICP病例。其中48例接受10%聚维酮碘治疗,被分配到干预组,其他48例接受无菌水治疗,并被分配到对照组,以防止在将ICP留置导尿管之前进行导管相关性UTI。 。主要结局是留置导管后发生尿路感染。次要结果是鉴定致病菌种。移除导管后评估结局。拔除导管后,两组之间UTI的发生率无显着差异(P = 0.34)。此外,两组之间在致病菌种类方面没有发现显着差异(大肠杆菌,P = 0.73;白色念珠菌,P = .57;肠球菌,P = .65;奇异变形杆菌,P = .50;柠檬酸杆菌, P = .50;肺炎克雷伯菌,P = .57)。使用10%聚维酮碘可能无法帮助减少ICP中的UTI。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号